Clinical Trials Logo

Tobacco Use Disorder clinical trials

View clinical trials related to Tobacco Use Disorder.

Filter by:

NCT ID: NCT04568395 Completed - Inflammation Clinical Trials

Acute Effects of TCIG vs ECIG in PLWH

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.

NCT ID: NCT04560868 Completed - Smoking Cessation Clinical Trials

Development of a mHealth Intervention for Ambivalent Smokers

Start date: December 16, 2020
Phase: Phase 1
Study type: Interventional

The current pilot study will assess the feasibility and acceptability of a novel mHealth app designed for people who are ambivalent about quitting smoking. Results will be used to refine the intervention and plan for a future randomized effectiveness trial.

NCT ID: NCT04535362 Completed - Nicotine Dependence Clinical Trials

Nicotine's Potential Abuse With Menthol

Start date: June 28, 2021
Phase: Early Phase 1
Study type: Interventional

To examine if switching from menthol to non-menthol cigarettes will change the dose-effect curves for positive subjective effects and alleviation of smoking urges as a function of nicotine delivery rate in smokers.

NCT ID: NCT04521647 Completed - Nicotine Dependence Clinical Trials

Effects of Menthol in E-cigarettes on Smoking Behaviors

Start date: May 10, 2022
Phase: Phase 1
Study type: Interventional

The overall goal of this proposal is to understand the relationship between nicotine metabolism and menthol flavor in e-cigarettes on smoking behavior in smokers.

NCT ID: NCT04506528 Completed - Cancer Clinical Trials

COVID EHR COHORT at the University of Wisconsin

CEC-UW
Start date: June 11, 2020
Phase:
Study type: Observational [Patient Registry]

This cohort study will obtain electronic health record (EHR) data (limited data set) from 21 health systems affiliated with the Cancer Center Cessation Initiative (C3I) network or health systems with large numbers of COVID-19 patients to explore whether smoking status, cancer history, and other risk factors among patients diagnosed with COVID-19 are associated with mortality and/or COVID-19 disease severity/complications. Each site will provide data from their health system EHR on a regular basis that includes all patients identified as having COVID-19 at some point in the interval from February 1, 2020, through January 31, 2022.

NCT ID: NCT04498988 Active, not recruiting - Clinical trials for Tobacco Use Disorder

Volitional Dysfunction in Self-control Failures and Addictive Behaviors

Start date: December 1, 2014
Phase:
Study type: Observational

The aim of this project is to elucidate whether impairments of cognitive control, performance-monitoring, and value-based decision-making and dysfunctional interactions between underlying brain systems are mediating mechanisms and vulnerability factors for daily self-control failures and addictive disorders.

NCT ID: NCT04490057 Active, not recruiting - Clinical trials for Tobacco Use Cessation

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

SMARTTT
Start date: July 27, 2020
Phase: Phase 4
Study type: Interventional

Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a group of PLWH.

NCT ID: NCT04487470 Recruiting - Clinical trials for Tobacco Use Disorder

Impact of Cigar Flavor in Dual Users

Start date: June 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to understand addiction to filtered cigars (FCs) compared to cigarettes in young adults, ages 21-34, who smoke both cigarettes and cigars. We are also looking to see if flavors, such as fruit or menthol, make FCs more addictive and if there are differences between men and women. Participants will receive 2 weeks supply of FCs, one week flavored and another week unflavored. You will be randomized (like flipping a coin) to which type of FC you will receive first. The study will: - take about 3-4 hours of your time per week over 3-5 weeks. - be conducted remotely by phone, video call, email, and mail. - require a smart phone to answer 5 quick surveys a day - you will need to answer 4 weekly surveys - take part in a weekly video or phone call with research staff - supply three saliva samples to be later tested for nicotine and other toxicants - and use a device to measure your carbon monoxide levels four times a day. You will be compensated for your time.

NCT ID: NCT04461288 Completed - Smoking Cessation Clinical Trials

Engaging Sexual and Gender Minority Cigarette Smokers Into Social Media-based Treatment

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

This research study will evaluate the preliminary efficacy of Pride Posts Plus, a social media-based smoking cessation treatment. A pilot randomized trial (N=120) will compare Pride Posts Plus, which includes a gamification element, to Pride Posts (without gamification) and to a usual care treatment. Participants will be adults who smoke, identify as sexual or gender minorities, and use Facebook. The primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be treatment engagement, a quit attempt (y/n), and thoughts about tobacco abstinence at 3 and 6 mos.

NCT ID: NCT04449510 Recruiting - Nicotine Dependence Clinical Trials

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH

TCORS-2
Start date: January 4, 2021
Phase: N/A
Study type: Interventional

This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim of the study is to assess the impact of changes in e-liquid pH on nicotine pharmacokinetics, cardiovascular, and subjective effects of e-cigarettes.